Measles, Mumps & Rubella Vaccine | Tresivac PFS - Serum

Advanced MMR Pediatric Immunization

When protecting children against the highly contagious and potentially severe viral diseases of Measles, Mumps, and Rubella (MMR), healthcare providers require a proven, safe, and highly immunogenic clinical intervention. The Measles, Mumps and Rubella Vaccine (Live) I.P. (Freeze-Dried) (commercially recognized as Tresivac PFS) provides targeted, active immunization. Manufactured by the Serum Institute of India (SII), a global powerhouse in pediatric immunology, this single-dose clinical kit ensures the steady clinical performance necessary for critical childhood immunization schedules.

Why Choose Tresivac PFS for Clinical Immunization?

Shielding patients from these three major viral infections requires a live-attenuated formulation to prompt a robust, long-lasting cellular and humoral immune response. Clinical specialists and pediatricians highly rely on Tresivac because it safely presents weakened forms of the viruses to establish lifelong immunity. The inclusion of a pre-filled syringe (PFS) for the diluent significantly minimizes preparation time, reduces the risk of contamination during reconstitution, and maximizes sterility in busy pediatric clinics.

Key Product Specifications & Clinical Benefits

Comprehensive 3-in-1 Protection: Delivers active immunity against Measles, Mumps, and Rubella in a single, highly effective dose.

Live Attenuated Formulation: Contains freeze-dried (lyophilized) live attenuated virus strains to safely establish a strong and lasting immune memory.

Complete Clinical Kit: Supplied as a convenient 0.5 ml single-dose, featuring the freeze-dried vaccine vial alongside a pre-filled syringe (PFS) containing the sterile diluent.

Targeted Administration: Formulated strictly for injection following reconstitution, guaranteeing optimal systemic immune activation.

Essential Storage & Usage Guidelines

Maintaining the delicate biological integrity of this live vaccine is absolutely vital for its clinical efficacy.

Strict Cold Chain: Store the vaccine strictly in a refrigerator between 2°C to 8°C (36°F to 46°F). Protect strictly from light.

Preparation: Reconstitute the freeze-dried powder only with the supplied diluent in the pre-filled syringe.

Immediate Use: Once reconstituted, the live vaccine must be protected from light and administered immediately (or within the timeframe specified in the clinical insert).

Important Notice: Tresivac is a Prescription Drug. It must be prescribed, handled, prepared, and administered strictly by a Registered Medical Practitioner in a clinical setting. Keep all medicines safely out of the reach of children.